Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB diagnosis news

Show

From To
South Africa Battles Drug-Resistant TB

Despite an increase in diagnosis times, South Africa is facing a growing drug-resistant tuberculosis (TB) burden as nationally there remains a large gap between the number of patients diagnosed with multidrug-resistant TB (MDR-TB) and those who start treatment.

Published
12 March 2014
From
Inter Press Service
Xpert TB test doesn’t reduce morbidity but it does have important advantages

While it is disappointing that the Xpert did not confer a morbidity or mortality benefit, its advantages include quicker and easier diagnosis with less work for health workers.

Published
10 March 2014
From
HIV i-Base
CROI 2014: GeneXpert real world study yields mixed results, highlights SA health system challenges

Gavin Churchyard and Katherine Fielding presented results this morning from the XPert for TB: Evaluating a New Diagnostic Trial (EXTEND) on the question of whether Xpert MTB/RIF diagnostic test reduces early mortality in adults with suspected TB, facilitates earlier initiation of TB treatment and antiretroviral therapy and reduces the number of patients

Published
05 March 2014
From
Science Speaks
GeneXpert use still hobbled by high pricing, Treatment Action Group, TB Community Advisory Board say

Letter to Cepheid cites continued cost of machines, Russia, China cartridge costs of five to six times negotiated price, and more.

Published
28 January 2014
From
Science Speaks
GLOBAL: Xpert MTB/RIF Test Quickly Detects TB and Resistance to Rifampicin

News-Medical.net reported on a second systematic review of the Xpert® MTB/RIF TB test, which is endorsed by the World Health Organization (WHO). WHO commissioned this updated Cochrane Review as part of the process to update the policy on the use of the test.

Published
23 January 2014
From
CDC National Prevention Information Network
Urgency Needed in the Global Response to Drug-resistant Tuberculosis

In the second of two linked posts, Lindsay McKenna and Colleen Daniels of Treatment Action Group (TAG) describe the importance of access to timely diagnosis and appropriate treatment for patients with drug-resistant tuberculosis and demand that urgency be returned to the global DR-TB response.

Published
04 November 2013
From
PLoS Blogs
Pros and cons of high-tech TB testing

A new, sophisticated diagnostic test for tuberculosis now being rolled out promises to be faster and more accurate than the old methods and much easier to use. But the first trials of the GeneXpert MTB/RIF Assay test in real-life situations have proved that while all this is true, it did not make any significant difference to treatment outcomes.

Published
30 October 2013
From
IRIN
Gains in tuberculosis control at risk due to 3 million missed patients and drug resistance

Tuberculosis (TB) treatment has saved the lives of more than 22 million people, according to the WHO "Global tuberculosis report 2013" published today. The report also reveals that the number of people ill with TB fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.

Published
23 October 2013
From
World Health Organization (press release)
London, tuberculosis capital of Western Europe, uses van with X-ray machine to detect TB

London may be famed for its historic sites, double-decker buses and West End shows, but it now has a more dubious distinction: It has become the tuberculosis capital of Western Europe.In response, health officials are taking to the streets in an effort to stop the spread of the infectious lung disease, with a high-tech white van equipped with an X-ray machine that drives around London offering free check-ups.

Published
23 October 2013
From
Washington Post
Public Health England plans national primary care TB screening programme

Public health officials are planning a nationally co-ordinated programme of targeted TB screening in primary care, to combat rising infection rates in some urban areas of England. Experts at Public Health England (PHE) claim the best way to ‘reverse the tide’ is for GP practices to start screening for latent TB in at-risk groups, particularly immigrants from areas with a high incidence of the disease.

Published
18 October 2013
From
Pulse

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.